Waddell & Reed Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Waddell & Reed Financial's DGX Position: Q1 2021 in Review
Waddell & Reed Financial increased its Quest Diagnostics (DGX) stake by 27% in Q1 2021, buying an estimated $8.83M and bringing the position to 334,904 shares worth $43M. The position accounts for 0.09% of the portfolio, ranked #273.
Waddell & Reed Financial first reported a position in DGX in Q3 2017 and has held it in 15 quarters since. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.
- Waddell & Reed Financial held 334,904 shares of Quest Diagnostics worth $43M as of Q1 2021.
- Waddell & Reed Financial bought 71,636 Quest Diagnostics shares in Q1 2021, an estimated $8.83M.
- Quest Diagnostics made up 0.09% of Waddell & Reed Financial's portfolio in Q1 2021, its #273 holding.
- Waddell & Reed Financial first reported a position in Quest Diagnostics in Q3 2017 and has held it in 15 quarters since.
- 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.
Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.